HK1016897A1 - Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities - Google Patents

Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities

Info

Publication number
HK1016897A1
HK1016897A1 HK99102199A HK99102199A HK1016897A1 HK 1016897 A1 HK1016897 A1 HK 1016897A1 HK 99102199 A HK99102199 A HK 99102199A HK 99102199 A HK99102199 A HK 99102199A HK 1016897 A1 HK1016897 A1 HK 1016897A1
Authority
HK
Hong Kong
Prior art keywords
myogenic cells
perceptive
abnormalities
peptide
relieving pain
Prior art date
Application number
HK99102199A
Other languages
English (en)
Inventor
Peter K Law
Original Assignee
Cell Therapy Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapy Res Foundation filed Critical Cell Therapy Res Foundation
Publication of HK1016897A1 publication Critical patent/HK1016897A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK99102199A 1997-08-11 1999-05-18 Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities HK1016897A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5519997P 1997-08-11 1997-08-11

Publications (1)

Publication Number Publication Date
HK1016897A1 true HK1016897A1 (en) 1999-11-12

Family

ID=21996302

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102199A HK1016897A1 (en) 1997-08-11 1999-05-18 Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities

Country Status (7)

Country Link
US (1) US7166279B2 (de)
EP (1) EP0898967B1 (de)
JP (1) JPH11147829A (de)
AT (1) ATE241992T1 (de)
CA (1) CA2225185A1 (de)
DE (1) DE69815230T2 (de)
HK (1) HK1016897A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007568A2 (en) 1999-07-23 2001-02-01 Diacrin, Inc. Muscle cells and their use in cardiac repair
EP1307582B1 (de) * 2000-08-08 2008-05-28 M.G.V.S. Ltd. Nukleinsäurekonstrukte, damit transformierte vaskuläre zellen, pharmezeutische zusammensetzungen und verfahren zur induktion der angiogenese
US7252819B2 (en) * 2001-11-08 2007-08-07 The Regents Of The University Of California Methods and compositions for correction of cardiac conduction disturbances
JP4549609B2 (ja) * 2002-04-11 2010-09-22 エスエス製薬株式会社 被覆固形催眠製剤
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
CA2487280A1 (en) * 2002-05-08 2003-11-20 The Regents Of The University Of California System and method for forming a substantially non-ablative cardiac conduction block
US6932804B2 (en) * 2003-01-21 2005-08-23 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US7317950B2 (en) * 2002-11-16 2008-01-08 The Regents Of The University Of California Cardiac stimulation system with delivery of conductive agent
JP2007534682A (ja) * 2004-04-26 2007-11-29 インミューンレーゲン バイオサイエンシズ インコーポレーティッド 老化防止効果を有するサブスタンスｐ
AU2006244197A1 (en) 2005-05-09 2006-11-16 Mytogen, Inc. Cellular cardiomyoplasty as supportive therapy in patients with heart disease
US20090017080A1 (en) * 2007-03-15 2009-01-15 Paul Robert Tanner Personal care kit having skin care compositions with a readily perceptible difference
US8518001B2 (en) * 2007-06-13 2013-08-27 The Procter & Gamble Company Skin treatment device
EP2296594A1 (de) * 2008-05-15 2011-03-23 Wyeth LLC Verfahren zur abgabe eines haut-benefit-mittels
US20100224205A1 (en) * 2008-12-09 2010-09-09 Shekhar Mitra Device and methods for modifying keratinous surfaces
CN102281794A (zh) 2009-01-16 2011-12-14 宝洁公司 改变角质表面的设备和方法
US20150050300A1 (en) 2013-08-16 2015-02-19 Peter K. Law Disease prevention and alleviation by human myoblast transplantation
KR101915375B1 (ko) 2014-06-13 2018-11-05 더 프록터 앤드 갬블 캄파니 각질 표면을 변경하는 장치 및 방법
JP2017526617A (ja) 2014-06-13 2017-09-14 ザ プロクター アンド ギャンブル カンパニー 角質表面を改質するためのトリートメント組成物、装置及び方法
US10156036B2 (en) 2014-06-13 2018-12-18 The Procter & Gamble Company Device and methods for applying compositions to fabric surfaces
US10518291B2 (en) 2014-06-13 2019-12-31 The Procter & Gamble Company Device and methods for modifying surfaces
US20160114349A1 (en) 2014-06-13 2016-04-28 The Procter & Gamble Company Device and methods for depositing materials on hard surfaces
US10188192B2 (en) 2014-06-13 2019-01-29 The Procter & Gamble Company Apparatus and methods for modifying keratinous surfaces
CA2949129C (en) 2014-06-13 2020-06-30 The Procter & Gamble Company Apparatus and methods for modifying keratinous surfaces
WO2015191831A2 (en) 2014-06-13 2015-12-17 The Procter & Gamble Company Cartridges for the deposition of treatment compositions on keratinous surfaces
KR101881739B1 (ko) 2014-06-13 2018-07-25 더 프록터 앤드 갬블 캄파니 각질 표면을 변경하는 장치 및 방법
US9949552B2 (en) 2014-07-25 2018-04-24 The Procter & Gamble Company Handheld treatment apparatus for modifying keratinous surfaces
US10314378B2 (en) 2014-07-25 2019-06-11 The Procter & Gamble Company Cartridge assembly for a dispensing device
US11083880B2 (en) 2014-07-25 2021-08-10 The Procter & Gamble Company Angled cartridge assembly for a dispensing device
US10188193B2 (en) 2014-07-25 2019-01-29 The Procter & Gamble Company Applicator heads for handheld treatment apparatus for modifying keratinous surfaces
US9955769B2 (en) 2014-07-25 2018-05-01 The Procter & Gamble Company Applicator heads for handheld treatment apparatus for modifying keratinous surfaces
US11116302B2 (en) 2015-06-11 2021-09-14 The Procter & Gamble Company Apparatus and methods for modifying keratinous surfaces
US9962532B2 (en) 2015-06-11 2018-05-08 The Procter & Gamble Company Cartridges for use in an apparatus for modifying keratinous surfaces
US9949547B2 (en) 2015-06-11 2018-04-24 The Procter & Gamble Company Cartridges for use in an apparatus for modifying keratinous surfaces
JP6878314B2 (ja) 2015-06-11 2021-05-26 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 表面に組成物を塗布するための装置及び方法
US9616668B1 (en) 2015-12-07 2017-04-11 The Procter & Gamble Company Servicing cassettes for handheld fluid jet apparatuses for use in modifying surfaces
US10166799B2 (en) 2015-12-07 2019-01-01 The Procter & Gamble Company Service stations for handheld fluid jet apparatuses
US10391042B2 (en) 2015-12-07 2019-08-27 The Procter & Gamble Company Treatment compositions, apparatus and methods for modifying keratinous surfaces
US11090238B2 (en) 2017-06-16 2021-08-17 The Procter & Gamble Company Array of cosmetic compositions for camouflaging tonal imperfections
EP3638195A1 (de) 2017-06-16 2020-04-22 The Procter and Gamble Company Computergestütztes kolorimetrisches make-up-verfahren zum überdecken von hautfarbabweichungen
WO2018231914A1 (en) 2017-06-16 2018-12-20 The Procter & Gamble Company Personal care device with audible feedback
WO2021089162A1 (en) 2019-11-07 2021-05-14 L'oreal Microdermabrasion device for coloring the skin
WO2023102287A1 (en) 2021-12-03 2023-06-08 The Procter & Gamble Company Personal care device with audible feedback

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE77033B1 (en) * 1989-08-16 1997-11-19 Univ Tulane Substance P antagonists
WO1992016547A1 (en) * 1991-03-15 1992-10-01 The Children's Medical Center Corporation Controlling nk-1 receptor-mediated responses and related diagnostics
CA2183167A1 (en) * 1994-12-13 1996-06-20 Peter K. Law Myoblast therapy for mammalian diseases

Also Published As

Publication number Publication date
JPH11147829A (ja) 1999-06-02
US20020044925A1 (en) 2002-04-18
DE69815230D1 (de) 2003-07-10
ATE241992T1 (de) 2003-06-15
US7166279B2 (en) 2007-01-23
DE69815230T2 (de) 2004-05-06
EP0898967A1 (de) 1999-03-03
EP0898967B1 (de) 2003-06-04
CA2225185A1 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
HK1016897A1 (en) Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities
NZ505011A (en) Expression vectors and cell lines expressing VEGF-D and method of treating melanomas
US6895271B2 (en) Iontophoretic drug delivery electrodes and method
TW286286B (de)
GB9211085D0 (en) Electrical stimulation
ATE127028T1 (de) Einpflanzbares iontophoretisches abgabesystem.
ATE223176T1 (de) Herzschrittmacher mit elektrode und integriertem sauerstoff-fühler
HK1030853A1 (en) Transdermal therapeutic device with capsaicin and capsaicin analogs
ES2161246T3 (es) Factor transformante de crecimiento alfa h1.
WO1994027491A3 (en) Intraoral-procedures electrode
Wheatley et al. A comparison of intact and in-vitro locomotion in an adult amphibian
HUT53816A (en) Method for elaborating therapeutical system feeding the agent gradually through the skin
AU5732190A (en) Glycoprotein hormone receptor molecules
FI970428A (fi) Soluja, joissa on CD4-houkutusreseptoreita ja vastaavia molekyylejä ja menetelmiä
CA2343893C (en) Iontophoretic drug delivery electrodes
IL136807A0 (en) Topical carbamazepine formulation and methods of use
CN2164852Y (zh) 全息胚穴位电极带
Wakelee-Lynch Interferon may offer first drug therapy for diabetic retinopathy. New research showing that alpha-interferon blocks new blood vessel formation in the iris of monkeys may point the way to new treatment for diabetes retinopathy
Barreiro et al. Treatment of postoperative pain for burn patients with intravenous analgesia in continuous perfusion using elastomeric infusors
Disselhoff Transcutaneous electrical nerve stimulation (TENS) in neuropathic pain
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
Qiang et al. Effect of auriculoacupuncture on life quality of patients with malignant tumors
Weaver Electroporation of Bacteria and Yeast: An Experimental Study of Molecular Transport
EP1839667A3 (de) Zellbasierte Gentherapie für das Lungensystem
Nix Changes in activity level as an aftereffect of stress

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: PETER KOI LAW

Free format text: FORMER OWNER(S): CELL THERAPY RESEARCH FOUNDATION

PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110407